San Francisco, 17 December 2018: The Report Stem Cells Market Analysis By Product (Adult
Stem Cells, hESC, Induced Pluripotent Stem Cells), By Application (Regenerative
Medicine, Drug Discovery), By Technology, By Therapy, And Segment Forecasts,
2018 - 2025
According to a report
published by Grand View Research, Inc.; the global stem cells market is projected
to reach around USD 15.63 billion by 2025. Increasing scope in clinical
applications can drive the market growth during the forecast period (2014 to
2025). Rising research activities focused on boosting the application scope of
stem cells is anticipated to positively influence market expansion in near
future. These research activities have opened new avenues in terms of
implementation of stem cells in regenerative medicine and disease management.
Technological innovations such
as continuous supply of induced Pluripotent Stem Cells (iPSCs) and efforts for
regeneration of diseased or dying cells are also expected to accelerate growth
of the market. Additionally, funding for R&D from government as well as
private organizations is expected to fuel the growth over the forecast period. Cellular
therapy is recognized as the next big advancement in healthcare sector. Efforts
from organizations to build their cellular therapy portfolio is expected to drive
the market.
The worldwide stem cells
market can be segmented on the basis of product, application, technology, therapy,
and region. Based on product, the market can be categorized into induced
pluripotent, adult, human embryonic, and very small embryonic like stem cells. Adult
stem cell segment is further divided into neuronal, mesenchymal, hematopoietic,
and umbilical cord, among others.
Access Research Report of Stem Cell Market@ www.grandviewresearch.com/industry-analysis/stem-cells-market
The adult stem cells segment
is anticipated to continue leading the market during the forecast period. Factors
such as long term renewal property and lesser rejection rate are driving the growth.
There are no ethical concerns associated with the use of these cells. This
factor is anticipated to bode well for the demand in near future. Also, research
activities related to organoid generation and drug screening are considered as
crucial factors for the segment growth.
As per application, the market
for stem cells can be categorized into regenerative medicine and drug discovery
and development. The regenerative medicine segment is further classified into
neurology, orthopedics, oncology, hematology, cardiovascular and myocardial
infraction, injuries, diabetes, liver disorders, and incontinence, among
others.
Regenerative medicine is
anticipated to hold a significant market share over the forecast period due to existence
of numerous pipeline projects. These medicines can cure traumatic injuries and
degenerative diseases. Neurology segment is anticipated to hold major market
share in terms of revenue owing to availability of the Food and Drug
Administration (FDA) approved products. Oncology segment is expected to grow on
account of presence of strong pipeline medicines for cancer therapies.
Browse more reports of this category by
Grand View Research at: www.grandviewresearch.com/industry/biotechnology
Based on technology, the stem
cells market is classified into cell acquisition, cryopreservation, cell
production, and expansion and sub-culture. Cell acquisition is further
categorized into bone marrow harvest, umbilical blood cord, and apheresis. The segment
is anticipated to occupy the largest market share throughout the forecast
period owing to their growing importance in cell harvesting. Development of new
cells using bone marrow is quicker therefore, it is the most preferred
technology. The cell production segment held substantial market share in the
past due to constant technological advancements to meet the ever-increasing
demand from clinical applications.
As per therapy, the market is
split into autologous and allogeneic stem cell therapy. In terms of revenue,
the autologous stem cell therapy segment led the market in 2016 due to high
acceptance of these products. Moreover, high compatibility of these cells is
anticipated to further propel the uptake over the forecast period.
Geographically, the market can
be divided into Europe, North America, Asia Pacific, Latin America, and Middle
East and Africa. North America is anticipated to account for a large market
share over the forecast period. Increasing R&D activities coupled with
funding for advanced cellular therapy is projected to bode well for the
regional market expansion. Asia Pacific is projected to showcase momentous
growth over the forecast period. Ongoing R&D projects in countries such as
Singapore, Australia, and Japan are projected impel the regional expansion.
Enhanced commercialization opportunities
are likely to further boost the market growth. Also, updated regulatory framework
related to regenerative medicine in Japan is projected to create business
opportunities in near future. North America holds the large share of the market.
This is credited to extensive R&D efforts and huge funding for advance
cellular research in the U.S.
Some of the leading companies operating in the stem cells
market include Cellular Engineering Technologies Inc.; BrainStorm Cell
Therapeutics; Bioheart Inc.; Advanced Cell Technology Inc.; and PromoCell GmbH.
Access
Press Release of Stem Cell Market@ www.grandviewresearch.com/press-release/global-stem-cells-market
About Grand View Research
Grand View Research, Inc. is a
U.S. based market research and consulting company, registered in the State of
California and headquartered in San Francisco. The company provides
syndicated research reports, customized research reports, and consulting
services. To help clients make informed business decisions, we offer market
intelligence studies ensuring relevant and fact-based research across a range
of industries, from technology to chemicals, materials and healthcare.
No comments:
Post a Comment